Adalimumab Therapy Restores the Gut Microbiota in Patients With Ankylosing Spondylitis
Open Access
- 1 September 2021
- journal article
- research article
- Published by Frontiers Media SA in Frontiers in Immunology
- Vol. 12
Abstract
Growing evidence suggests that the gut microbiota is involved in the initiation and progression of ankylosing spondylitis (AS). In this study, we aimed to explore the gut microbiome alterations during adalimumab therapy and verify microbiome biomarkers predicting treatment response. By evaluating the gut microbial features of 30 AS patients before and after adalimumab therapy for 6 months and 24 healthy controls, we confirmed that the microbiome was restored remarkably after 6 months of adalimumab therapy in AS patients. We then compared the baseline gut microbiome of 22 adalimumab responders with 8 non-responders, a higher abundance of Comamonas was revealed in the latter, although no statistical difference was found after adjusting for the false discovery rate. These results suggested that adalimumab therapy restored the gut microbiome in AS patients and indicated the utility of gut microbiome to be potential biomarkers for therapeutic evaluation. These findings provided an insight into the development of predictive tools and the establishment of precise medical interventions for clinical practice.Keywords
This publication has 31 references indexed in Scilit:
- Ankylosing Spondylitis and Axial SpondyloarthritisNew England Journal of Medicine, 2016
- Perturbed Mucosal Immunity and Dysbiosis Accompany Clinical Disease in a Rat Model of SpondyloarthritisArthritis & Rheumatology, 2016
- Improved Bacterial 16S rRNA Gene (V4 and V4-5) and Fungal Internal Transcribed Spacer Marker Gene Primers for Microbial Community SurveysmSystems, 2016
- Anti-TNF Therapy Response in Patients with Ulcerative Colitis Is Associated with Colonic Antimicrobial Peptide Expression and Microbiota CompositionJournal of Crohn's and Colitis, 2016
- The oral and gut microbiomes are perturbed in rheumatoid arthritis and partly normalized after treatmentNature Medicine, 2015
- Using QIIME to Analyze 16S rRNA Gene Sequences from Microbial CommunitiesCurrent Protocols in Microbiology, 2012
- Ankylosing Spondylitis Disease Activity Score (ASDAS): defining cut-off values for disease activity states and improvement scoresAnnals of the Rheumatic Diseases, 2011
- UniFrac: an effective distance metric for microbial community comparisonThe ISME Journal, 2010
- Scale and species richness: towards a general, hierarchical theory of species diversityJournal of Biogeography, 2001
- Evaluation of Diagnostic Criteria for Ankylosing SpondylitisArthritis & Rheumatism, 1984